Accueil
| Titre : | European Archives of Psychiatry and Clinical Neuroscience, Vol.269, n°1. Cannabis and mental health: risks and benefits - February 2019 |
| Type de document : | Bulletin |
| Paru le : | 01/02/2019 |
Dépouillements
Ajouter le résultat dans votre panierArticle : Périodique
ENGLISH:Through the potency monitoring program at the University of Mississippi supported by National Institute on Drug Abuse (NIDA), a total of 18108 samples of cannabis preparations have been analyzed over the last decade, using a validated GC[...]
Article : Périodique
Confusion and controversy related to the potential for cannabis use to cause harm, or alternatively to provide benefit, continues globally. This issue has grown in intensity and importance with the increased recognition of the public health impl[...]
Article : Périodique
E. HOCH ;
D. NIEMANN ;
R. VON KELLER ;
M. SCHNEIDER ;
C. M. FRIEMEL ;
U. W. PREUSS ;
A. HASAN ;
O. POGARELL
|
We conducted a review of systematic reviews (SRs) and randomized-controlled trials (RCTs) to analyze efficacy and safety of cannabis-based medication in patients with mental disorders. Five data bases were systematically searched (2006-August 20[...]
Article : Périodique
With the increasing push to legalize cannabis in Western nations, there is a need to gage the potential impact of this policy change on vulnerable populations, such as those with mental illness, including schizophrenia, mood, and anxiety disorde[...]
